News

Progyny Lands Employer Benefits Expert in Expansion of Leadership Team

Arielle Bogorad joins Progyny as Senior Vice President of Employer Market StrategyNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Progyny,…

2 years ago

Signati™ Medical, Inc. Debuts Innovative Bipolar Radio Frequency Sealing Platform at American Urological Association (AUA) Annual Meeting

Providence, RI, May 24, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. is pleased to announce the unveiling of their innovative…

2 years ago

AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures

SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international…

2 years ago

SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment

Pre-clinical trials based on the proprietary combination demonstrate significant suppressive effect on alcohol consumption TEL AVIV, Israel, May 24, 2022…

2 years ago

P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports

HENDERSON, Nev., May 24, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered…

2 years ago

Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity

SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage…

2 years ago

Agenus Announces Late-Breaking Oral Presentation at ESMO-GI and Strategies to Advance Botensilimab

Data to be Presented in Heavily Pretreated MSS-CRCSpeed and Innovation Core to Development StrategyReduction of 20% in 2022 Operating CostsLEXINGTON,…

2 years ago

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital…

2 years ago

Clearmind Medicine and SciSparc Collaboration Yields Positive Results for its Psychedelic Combination Treatment

Pre-clinical trial based on the proprietary combination demonstrates high safety profile in addition to a significant suppressive effect on alcohol…

2 years ago

TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense

DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as…

2 years ago